<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2020000300201</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2020000300009</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Abordaje nutricional en pacientes críticos diagnosticados de neumonía por COVID-19]]></article-title>
<article-title xml:lang="en"><![CDATA[Nutritional approach in critical patients diagnosed with pneumonia by COVID-19]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rubio Alonso]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montero Hernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Pons]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Belló Crespo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soler Company]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Arnau de Vilanova-Lliria  ]]></institution>
<addr-line><![CDATA[Valencia ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>30</volume>
<numero>3</numero>
<fpage>201</fpage>
<lpage>205</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2020000300201&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2020000300201&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2020000300201&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Evaluar las actuaciones nutricionales en pacientes con diagnóstico de neumonía COVID-19 en una Unidad de Cuidados Intensivos (UCI) y su ajuste a las guías de las sociedades Europea y Americana de Nutrición Clínica.  Metodología:  Estudio retrospectivo observacional de 2 meses de duración en pacientes con diagnóstico de neumonía COVID-19 con ingreso en UCI. Se utilizaron los programas ICCA®, OrionClinic® y Kabisoft® para obtener las variables de los pacientes.  Resultados:  Ingresaron 27 pacientes, de los cuales 20 precisaron soporte nutricional. Un 65% eran hombres y la media de edad fue 62±13,2 años. Los requerimientos energéticos teóricos fueron entre 1.535-1.800 Kcal/día. Permanecieron 2,5±4,5 días en planta previo a su estancia en UCI, que fue de 17±6,9 días. Al término del estudio, el 15% de pacientes fueron alta, el 35% seguían hospitalizados y el 50% fueron éxitus. La variación de los datos analíticos al ingreso y alta fue: proteínas +1,3 g/dl, albúmina +1,2 g/dl, linfocitos +0,5*103/mm3, PCR -114,5 mg/l y triglicéridos +19,4 mg/dl. Un 10% recibieron remdesivir y un 30% tocilizumab como tratamientos de segunda línea. Todos fueron intubados y tratados con propofol; el 75% requirió posición decúbito prono. Todos los pacientes requirieron nutrición enteral, siendo la fórmula hiperproteica-hipercalórica con fibra la más utilizada. Un 70% necesitó nutrición parenteral total, utilizándose formulaciones hiperproteicas-hipocalóricas de forma prioritaria y suplementadas con vitaminas y oligoelementos.  Conclusión:  Dentro del complicado manejo de este tipo de pacientes, las intervenciones nutricionales han sido necesarias en un 75% de ellos y la adherencia a las guías actuales se ha dado en todos los casos, con resultados favorables.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Purpose:  Evaluate nutritional performance in patients with COVID-19 pneumonia admitted to the Intensive Care Unit (ICU). Adjustment done following the guidelines of the European and American societies for Clinical Nutrition.  Methodology:  Retrospective observational during 2 months study of some patients with pneumonia by COVID-19 in ICU. Informatic programs ICCA®, OrionClinic® and Kabisoft® were used to obtain variables of patients.  Results:  27 patients were admitted in ICU, while 20 of them required nutritional support. There were 65% of men with average age about 62±13.2. Their theoretical nutritional requirements were between 1,535-1,800 kcal/day. They stayed 2.5±4.5 days in the hospital before their ICU admission. They were 17±6.9 days on average in ICU. At the end of this study, 15% of patients were discharged, 35% were hospitalized, and 50% were dead. The variation of the analytical data at admission and discharge was: proteins +1.3 g/dl, albumin +1.2 g/dl, lymphocytes +0.5*103/mm3, PCR -114.5 mg/l and triglycerides +19.4 mg/dl. 10% took remdesivir and 30% tocilizumab. All of them were intubated and treated with propofol and 75% required prone position. All of patients required enteral nutrition being the hyperprotein-hypercaloric with fiber formula the most used. 70% required central total parenteral nutrition being mostly hyperprotein-hypocaloric and supplemented with vitamins and trace elements.  Conclusion:  Within the complicated management of this type of patients, nutritional interventions have been necessary in 75% of them and adherence to current guidelines has occurred in all cases, with favorable results.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[enfermedad crítica]]></kwd>
<kwd lng="es"><![CDATA[soporte nutricional]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[nutritional support]]></kwd>
<kwd lng="en"><![CDATA[critically ill patients]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<source><![CDATA[Información científica-técnica. Enfermedad por coronavirus, COVID-19]]></source>
<year>2020</year>
<publisher-name><![CDATA[Centro de Coordinación de Alertas y Emergencias Sanitarias. Ministerio de Sanidad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<source><![CDATA[Actualización nº 89. Enfermedad por coronavirus (COVID-19)]]></source>
<year>2020</year>
<publisher-name><![CDATA[Situación en España. Centro de Coordinación de Alertas y Emergencias Sanitarias. Ministerio de Sanidad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<source><![CDATA[Ámbito de actuación]]></source>
<year></year>
<publisher-name><![CDATA[Departamento de Salud Arnau de Vilanova-Llíria]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McClave]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Martindale]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Warren]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Braunschweig]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)]]></article-title>
<source><![CDATA[J Parenter Enter Nutr]]></source>
<year>2016</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>159-211</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Zanten]]></surname>
<given-names><![CDATA[ARH]]></given-names>
</name>
<name>
<surname><![CDATA[De Waele]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wischmeyer]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nutrition therapy and critical illness: Practical guidance for the icu, post-icu, and long-term convalescence phases. Critical Care]]></article-title>
<source><![CDATA[BioMed Central]]></source>
<year>2019</year>
<volume>23</volume>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barazzoni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bischoff]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Breda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wickramasinghe]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Krznaric]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Nitzan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection]]></article-title>
<source><![CDATA[]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martindale]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mcclave Md -Professor]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Ye]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cui]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Niu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kunz]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Trial of Lopinavir-Ritonavir in Covid-19]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>21</numero>
<issue>21</issue>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[IF-N]]></given-names>
</name>
<name>
<surname><![CDATA[Lung]]></surname>
<given-names><![CDATA[K-C]]></given-names>
</name>
<name>
<surname><![CDATA[Tso]]></surname>
<given-names><![CDATA[EY-K]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[TW-H]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[M-Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effective treatment of severe COVID-19 patients with tocilizumab]]></article-title>
<source><![CDATA[Proc Natl Acad Sci]]></source>
<year>2020</year>
<volume>117</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>10970-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<source><![CDATA[Ficha técnica Betaferón 250 microgramos/ml, polvo y disolvente para solución inyectable]]></source>
<year>2020</year>
<publisher-name><![CDATA[Agencia Europea del Medicamento (EMA)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="">
<source><![CDATA[Ficha técnica Roactemra 20mg/ml, concentrado para solución para perfusión]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="">
<source><![CDATA[Fact Sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urquizo Ayala]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Arteaga Coarite]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Patricia Chacón Yucra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilidad de los reactantes de fase aguda en el diagnóstico clínico]]></article-title>
<source><![CDATA[Rev. Méd. La Paz]]></source>
<year>2019</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hou]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19]]></article-title>
<source><![CDATA[Clin Exp Immunol]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ulíbarri]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[González-Madroño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[de Villar]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mancha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CONUT: a tool for controlling nutritional status. First validation in a hospital population]]></article-title>
<source><![CDATA[Nutr Hosp]]></source>
<year>2005</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-45</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ohmagari]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Asperges]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castagna]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Compassionate Use of Remdesivir for Patients with Severe Covid-19]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rahat]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Feld]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Elias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rosner]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Kaly]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2019</year>
<volume>20</volume>
<numero>18</numero>
<issue>18</issue>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bousie]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[van Blokland]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lammers]]></surname>
<given-names><![CDATA[HJW]]></given-names>
</name>
<name>
<surname><![CDATA[van Zanten]]></surname>
<given-names><![CDATA[ARH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relevance of non-nutritional calories in mechanically ventilated critically ill patients]]></article-title>
<source><![CDATA[Eur J Clin Nutr]]></source>
<year>2016</year>
<volume>70</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1443-50</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bilotta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dauri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Macheda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pujia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[De Santis]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short Report - Medical nutrition therapy for critically ill patients with COVID-19]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2020</year>
<volume>24</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>4035-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laurence]]></surname>
<given-names><![CDATA[Harbige]]></given-names>
</name>
<name>
<surname><![CDATA[Philip]]></surname>
<given-names><![CDATA[Calder]]></given-names>
</name>
<name>
<surname><![CDATA[Ascensión]]></surname>
<given-names><![CDATA[Marcos]]></given-names>
</name>
<name>
<surname><![CDATA[Mireille]]></surname>
<given-names><![CDATA[Dardenne]]></given-names>
</name>
<name>
<surname><![CDATA[Gabriela]]></surname>
<given-names><![CDATA[Perdigón]]></given-names>
</name>
<name>
<surname><![CDATA[Francisco]]></surname>
<given-names><![CDATA[Pérez-Cano]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[Savino]]></given-names>
</name>
<name>
<surname><![CDATA[Nora]]></surname>
<given-names><![CDATA[Slobodianik]]></given-names>
</name>
<name>
<surname><![CDATA[Solano Liseti]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
</person-group>
<source><![CDATA[ISIN Position Statement on Nutrition, Immunity and COVID-19]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
